Funder
Merck Sharp & Dohme Corp.
Merck & Co., Inc.
Sumitomo Dainippon Pharma
MSD
Gilliad
Dainippon Sumitomo
Boehringer Ingelheim
Sanofi
Ono Pharmaceutical
Taiho Pharmaceutical
Bayer
Hisamitsu
Daiichi Sankyo
Japan Agency for Medical Research and Development
AstraZeneca
Merck Serono
Eisai
LSK BioPharma
Incyte
Pfizer
Boehringer-Ingelheim
BeiGene
Shionogi & Co
Takeda Pharmaceutical
Shin Nippon Biomedical Laboratories
Novartis
Toyama Chemical
Bristol-Myers Squibb
Five Prime
Astellas
Nihon Kayaku
Abbott
AbbVie
Biogen
Celgene
GlaxoSmithKline
KCI
Kyowa Kirin
Meiji Seika Pharma
Toray Medical
National Cancer Center Hospital
NanoCarrier
Baxter International Inc.
Clinical Co., Ltd
Quintiles and IMS Health
Sysmex Corporation
Mediscience Planning Inc
Asahi Kasei Pharma Corporation
Nippon Zoki Pharmaceutical
Chugai Pharmaceutical
MediScience
Reference36 articles.
1. New Global Cancer Data: Globocan 2018. https://www.uicc.org/news/new-global-cancer-data-globocan-2018.
2. National Cancer Center, Japan. Cancer registry and statistics (in Japanese),2018
3. Japanese gastric cancer treatment guidelines 2014 (ver. 4);Gastric Cancer,2017
4. NCCN clinical practice guidelines in Oncology;National Comprehensive Cancer Network,2019
5. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Smyth;Ann Oncol,2016
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献